ITAB

Welcome to the Brand page for “ITAB”, which is offered here for Pharmaceuticals, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, b-cell disorders, and minimal residual diseases, in the form of intravenous, sub-cutaneous, intraperitoneal, intra-muscular and aerosol therapies;.

Its status is currently believed to be active. Its class is unavailable. “ITAB” is believed to be currently owned by “Generon (Shanghai) Corporation Ltd.”